Porous carbon particles for use in the treatment or prevention of liver disease

Carol Howell; Sergey Mikhalovsky; Susan Sandeman; Rajiv Jalan; Jane Macnaughtan

Porous carbon particles for use in the treatment or prevention of liver disease

Carol Howell (Inventor)
, Sergey Mikhalovsky (Inventor)
, Susan Sandeman (Inventor)
, Rajiv Jalan (Inventor)
, Jane Macnaughtan (Inventor)

Research output: Patent

Abstract

The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

Original language	English
Publication status	Published - 19 Sept 2013

Cite this

@misc{7ef224176a89423893ed6c70d5db6575,

title = "Porous carbon particles for use in the treatment or prevention of liver disease",

abstract = "The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20\% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.",

author = "Carol Howell and Sergey Mikhalovsky and Susan Sandeman and Rajiv Jalan and Jane Macnaughtan",

year = "2013",

month = sep,

day = "19",

language = "English",

type = "Patent",

}

TY - PAT

T1 - Porous carbon particles for use in the treatment or prevention of liver disease

AU - Howell, Carol

AU - Mikhalovsky, Sergey

AU - Sandeman, Susan

AU - Jalan, Rajiv

AU - Macnaughtan, Jane

PY - 2013/9/19

Y1 - 2013/9/19

N2 - The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

AB - The invention provides porous carbon particles for use in the treatment or prevention of liver disease, wherein at least 20% of the total pore volume is made up of pores having a mean diameter of from 2 to 200 nm and/or wherein the particles comprise micropores of diameter 2 nm or less and small macropores of diameter 50 nm to 500 nm, but substantially no mesopores of diameter greater than 2 nm and less than 50 nm, and substantially no large macropores of diameter greater than 500 nm.

M3 - Patent

ER -

Porous carbon particles for use in the treatment or prevention of liver disease

Abstract

Fingerprint

Cite this